Martingale Asset Management L P trimmed its position in shares of Humana Inc (NYSE:HUM) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 99,068 shares of the insurance provider’s stock after selling 2,071 shares during the period. Martingale Asset Management L P owned approximately 0.07% of Humana worth $24,577,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Fieldpoint Private Securities LLC acquired a new stake in Humana during the third quarter valued at approximately $115,000. ClariVest Asset Management LLC acquired a new stake in Humana during the third quarter valued at approximately $144,000. Daiwa SB Investments Ltd. boosted its holdings in Humana by 44.9% during the fourth quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after purchasing an additional 220 shares in the last quarter. Virtu Financial LLC acquired a new stake in Humana during the fourth quarter valued at approximately $204,000. Finally, Pettee Investors Inc. acquired a new stake in Humana during the third quarter valued at approximately $207,000. 97.68% of the stock is currently owned by institutional investors.
In other Humana news, SVP Jody L. Bilney sold 7,054 shares of the company’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Timothy S. Huval sold 1,382 shares of the company’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the transaction, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,115 shares of company stock worth $2,501,627. Company insiders own 0.80% of the company’s stock.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping the consensus estimate of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The business had revenue of $13.19 billion for the quarter, compared to the consensus estimate of $13.14 billion. During the same period in the previous year, the business earned $2.34 EPS. Humana’s revenue was up 2.4% compared to the same quarter last year. research analysts anticipate that Humana Inc will post 13.86 earnings per share for the current fiscal year.
Humana declared that its board has initiated a stock repurchase program on Thursday, December 14th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s board believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be issued a dividend of $0.50 per share. This is an increase from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $2.00 annualized dividend and a yield of 0.75%. Humana’s dividend payout ratio is currently 9.59%.
A number of equities research analysts have weighed in on HUM shares. Credit Suisse Group decreased their price objective on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a report on Friday, November 10th. BMO Capital Markets lifted their price objective on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a report on Friday, November 10th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $242.00 price objective (down from $245.00) on shares of Humana in a report on Thursday, November 9th. Jefferies Group raised Humana from a “hold” rating to a “buy” rating and set a $221.00 price objective on the stock in a report on Friday, January 12th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $230.00 price objective on shares of Humana in a report on Tuesday, December 5th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $270.47.
COPYRIGHT VIOLATION WARNING: “Martingale Asset Management L P Lowers Position in Humana Inc (HUM)” was posted by Week Herald and is the property of of Week Herald. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://weekherald.com/2018/02/23/martingale-asset-management-l-p-lowers-position-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.